141 related articles for article (PubMed ID: 28621641)
1. Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.
Chung ES; Lee JY; Rhee JY; Ko KS
J Med Microbiol; 2017 Jun; 66(6):833-841. PubMed ID: 28621641
[TBL] [Abstract][Full Text] [Related]
2. Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.
Lee JY; Chung ES; Na IY; Kim H; Shin D; Ko KS
J Antimicrob Chemother; 2014 Nov; 69(11):2966-71. PubMed ID: 24994873
[TBL] [Abstract][Full Text] [Related]
3. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
4. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
5. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
6. Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose in polymyxin-resistant mutants of Escherichia coli. An aminotransferase (ArnB) that generates UDP-4-deoxyl-L-arabinose.
Breazeale SD; Ribeiro AA; Raetz CR
J Biol Chem; 2003 Jul; 278(27):24731-9. PubMed ID: 12704196
[TBL] [Abstract][Full Text] [Related]
7. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
8. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
[TBL] [Abstract][Full Text] [Related]
9. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
10. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.
Ly NS; Yang J; Bulitta JB; Tsuji BT
Antimicrob Agents Chemother; 2012 Jun; 56(6):3453-6. PubMed ID: 22470116
[TBL] [Abstract][Full Text] [Related]
11. Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa.
Lee JY; Park YK; Chung ES; Na IY; Ko KS
Sci Rep; 2016 May; 6():25543. PubMed ID: 27150578
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
[TBL] [Abstract][Full Text] [Related]
13. Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa.
Lo Sciuto A; Imperi F
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263076
[TBL] [Abstract][Full Text] [Related]
14. A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose.
Breazeale SD; Ribeiro AA; McClerren AL; Raetz CR
J Biol Chem; 2005 Apr; 280(14):14154-67. PubMed ID: 15695810
[TBL] [Abstract][Full Text] [Related]
15. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
Lee JY; Choi MJ; Choi HJ; Ko KS
Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
[TBL] [Abstract][Full Text] [Related]
16. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
[TBL] [Abstract][Full Text] [Related]
17. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
Gutu AD; Sgambati N; Strasbourger P; Brannon MK; Jacobs MA; Haugen E; Kaul RK; Johansen HK; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2013 May; 57(5):2204-15. PubMed ID: 23459479
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of PmrA and PmrB genes in colistin-resistant Pseudomonas aeruginosa strains via PCR method.
Heidari L; Sepahvand S; Darvishi M; Jafari R
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1175-1177. PubMed ID: 31303587
[TBL] [Abstract][Full Text] [Related]
19. Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae.
Cheng YH; Lin TL; Lin YT; Wang JT
Antimicrob Agents Chemother; 2016 Jun; 60(6):3709-16. PubMed ID: 27067316
[TBL] [Abstract][Full Text] [Related]
20. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.
Lee JY; Na IY; Park YK; Ko KS
J Antimicrob Chemother; 2014 May; 69(5):1248-56. PubMed ID: 24474431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
